Compare OTC markets in six Central European countries Third edition report analyses current conditions and offers forecasts to 2014
Experts on Central European economies have joined together with PMR’s most experienced pharmaceutical sector analysts to produce the fifth edition of this comprehensive analysis of the OTC drug and dietary supplement markets in six regional countries: Poland, Romania, the Czech Republic, Hungary, Bulgaria and Slovakia. More than 200 pages in length, this document offers breakdowns of complex market issues and examines historical data, current topics and growth projections.
OTC market in Central Europe 2012, Comparative analysis and development forecasts for 2012-2014 offers data, in-depth analysis and accurate forecasts. It provides value estimates for the OTC product segment, coverage of the activities of the leading manufacturers of OTC products and the top selling preparations in each of the six countries included in the scope of the publication.
This convenient document offers descriptions of the OTC drug and dietary supplements shares of the overall pharmaceutical markets, as well as market structures prevalent in each country. It offers value data from 2009 to 2014 for each specific country in order to supply an historical perspective on recent market development. It provides current operational data as well as updates on the foremost pharmacy chains, OTC product wholesale distributors, online and non-pharmacy sales, newsworthy events and influential trends at work in each of these CE OTC markets.
The report also features profiles of the principal local OTC product manufacturers in Central Europe along with information on leaders in each specific country. It delves into the regulatory environments in place in each of the covered countries, especially with regard to Internet sales and non-pharmacy options, analysing current and upcoming legislation and applying developments to market conditions in order to accurately predict the results.
The publication includes an evaluation of consumer behaviour and a country-by –country assessment of advertising that spotlights the companies with the highest spending in terms of campaigns designed to promote their products. Epidemiological trends are also examined in terms of their effects on product planning, development and changes in purchasing.
OTC market in Central Europe 2012, Comparative analysis and development forecasts for 2012-2014 features extensive and accurate projections for market growth in Poland, Romania, the Czech Republic, Hungary, Bulgaria and Slovakia. This feature is especially helpful to readers engaged in beginning business operations in one or more of the covered markets, to those expanding operations and increasing product lines and those designing long term corporate strategies.
Manufacturers, wholesalers, distributors and retailers of OTC drugs and dietary supplements in Central Europe will appreciate the comparative analysis as well as comprehensive collection of data, which answers their questions as to market saturation, regulatory restrictions, market potential and popular corporate strategy.